Intravenous Immunoglobulins FDA Link

Immunoglobulin preparations used in intravenous infusion, containing primarily IMMUNOGLOBULIN G. They are used to treat a variety of diseases associated with decreased or abnormal immunoglobulin levels including pediatric AIDS; primary HYPERGAMMAGLOBULINEMIA; SCID; CYTOMEGALOVIRUS infections in transplant recipients, LYMPHOCYTIC LEUKEMIA, CHRONIC; Kawasaki syndrome, infection in neonates, and IDIOPATHIC THROMBOCYTOPENIC PURPURA.

Also Known As:

IVIG; Immunoglobulins, Intravenous; Alphaglobin; Endobulin; Flebogamma DIF; Gamimmune; Gamimmune N; Gamimune; Gamimune N; Gammagard; Gammonativ; Gamunex; Globulin-N; IV Immunoglobulins; Immune Globulin Intravenous (Human); Immune Globulin, Intravenous; Immunoglobulins, Intravenous, Human; Intraglobin; Intraglobin F; Intravenous IG; Intravenous Immunoglobulins, Human; Iveegam; Modified Immune Globulin (Anti-Echovirus Antibody); Privigen; Sandoglobulin; Venimmune; Venoglobulin; Venoglobulin-I; Globulin N; Human Intravenous Immunoglobulins; Immunoglobulin, Human Intravenous; Immunoglobulin, IV; Immunoglobulin, Intravenous; Immunoglobulins, Human Intravenous; Immunoglobulins, IV; Intravenous Immune Globulin; Intravenous Immunoglobulin, Human; Venoglobulin I; Antibodies, Intravenous; Human Intravenous Immunoglobulin; IV Immunoglobulin; Intravenous Antibodies; Intravenous Immunoglobulin

Pharmalogical Action Categories:

Immunologic Factors

Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Blood Proteins: 12459
    - Serum Globulins: 553
      - Immunoglobulins: 30480
        Antibodies: 133716
        Intravenous Immunoglobulins: 10137
    - Immunoproteins: 43
      - Immunoglobulins: 30480
        Antibodies: 133716
        Intravenous Immunoglobulins: 10137
        Immunoglobulin Isotypes: 1085
        Immunoglobulin G: 58863
        Intravenous Immunoglobulins: 10137
  - Globulins: 3062
    - Serum Globulins: 553
      - Immunoglobulins: 30480
        Antibodies: 133716
        Intravenous Immunoglobulins: 10137

Keren Smuel Selected Research

Keren Smuel Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure